Toward an integrated approach to molecular epidemiology

American Journal of Epidemiology

Volumn 146, Issue 11, 1997, Pages 912-918

  Ambrosone, Christine B ^a   Kadlubar, Fred F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biological markers; Disease susceptibility; Disease susceptibility, genetics; Epidemiologic methods; Epidemiology; Epidemiology, molecular, trends; Epidemiology, molecular. methods

Indexed keywords

BIOLOGICAL MARKER;

DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; GENETIC EPIDEMIOLOGY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; REVIEW;

EID: 0030780753     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009217     Document Type: Review

References (34)

1. Susser M, Susser E. Choosing a future for epidemiology. I. Eras and paradigms. Am J Public Health 1996:86:668-73.
2. Susser M, Susser E. Choosing a future for epidemiology. II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health 1996;86:674-7.
3. Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am J Public Health 1996;86:678-83.
4. Winkelstein W. Editorial: Eras, paradigms, and the future of epidemiology. Am J Public Health 1996;86:621-2.
5. McKinlay JB. Towards appropriate levels of analysis, research methods and health public policy. International Symposium on Quality of Life and Health: Theoretical and Methodological Considerations. Berlin, Germany, May 25-27, 1994.
6. Caporaso NE, Landi MT. Molecular epidemiology: a new perspective for the study of toxic exposures in man. A consideration of the influence of genetic susceptibility factors on risk in different lung cancer histologies. Med Lav 1994;85: 68-77.
7. Groopman JD, Skipper PL. Molecular dosimetry and human cancer: analytical, epidemiological, and social considerations. Boca Raton, FL: CRC Press, Inc., 1991.
8. Vineis P, Marione T. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology 1995;6: 455-7.
9. Perera FP, Mooney LA, Dickey CP, et al. Molecular epidemiology in environmental carcinogenesis. Environ Health Perspect 1996;104 (Suppl. 3):441-3.
10. Soderkvist P, Axelson O. On the use of molecular biology data in occupational and environmental epidemiology. J Occup Environ Med 1995;37:84-90.
11. Weinstein IB. The contribution of molecular biology to cancer epidemiology. Ann N Y Acad Sei 1995;768:30-40.
12. Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88:496-509.
13. Pearce N, de Sanjose S, Boffetta P, et al. Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology 1995;6:190-4.
14. McMichael AJ. Invited commentary-"molecular epidemiology": new pathway or new travelling companion? Am J Epidemiol 1994; 140:1-11.
15. Schulte PA, Perera FP, eds. Molecular epidemiology: principles and practices. San Diego, CA: Academic Press, Inc., 1993.
16. Albertini RJ, Nicklas JA, O'Neill JP. Future research directions for evaluating human genetic and cancer risk from environmental exposures. Environ Health Perspect 1996;104: 503-10.
17. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutât Res 1991;247:267-81.
18. Evans DAP. N-Acetyltransferase. Pharmacol Ther 1989;42: 157-234.
19. Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase Ml (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
20. Nakachi K, Imai K, Hayashi S, et al. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51:5177-80.
21. Lang NP, Butler MA, Massengill J, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 1994;3:675-82.
22. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-501.
23. Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiologie Rev 1993;15:145-56.
24. Hulka BS, Wilcosky TC, Griffith JD, eds. Biological markers in epidemiology. New York, NY: Oxford University Press, 1990.
25. Wogan GN, Gorelick NJ. An overview of chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect 1985;62:5-18.
26. Li D, Wang M, Dhingra K, et al. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996;56:287-93.
27. Perera FP, Estabrook A, Hewer A, et al. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 1995;4:233-8.
28. Wang M, Dhingra K, Hittleman WN, et al. Lipid peroxidationinduced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev 1996;5: 705-10.
29. Spencer GG, Wood DP Jr, Gupta RC. Detection of DNA adducts in normal and tumorous human prostate biopsies by 32P-postlabeling. Int J Oncol 1995;7:245-8.
30. Denissenko MF, Pao A, Tang MS, et al. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53. Science 1996;274:430-2.
31. Snow J. On the mode of communication of cholera. 2nd ed. London, England: J. Churchill, 1855. Reprinted as: Snow on cholera. New York, NY: Commonwealth Fund, 1936.
32. Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994;3:173-5.
33. Piegorsch VAV, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 1994; 13:153-62.
34. Dipple A. Formation, metabolism, and mechanism of action of polycyclic aromatic hydrocarbons. Cancer Res 1983;43 (Suppl.):2422s-5s. -